HB254, titled the American Science First Act, would bar the Director of the National Science Foundation from awarding grants or other forms of assistance to individuals or entities that have specified ties to Chinese communist military companies. The bill covers recipients that are affiliated with, or have relationships such as research partnerships, joint ventures, or contracts with, entities identified on federal restricted lists, including companies listed under the Export Administration Regulations and certain Department of Defense-related lists. It also extends the prohibition to parent companies, subsidiaries, affiliates, and entities owned or controlled by those listed entities.
The measure is aimed at preventing NSF funding from indirectly supporting organizations connected to Chinese military or defense interests. In practical terms, it would require the NSF to screen applicants and their business or research relationships more closely before awarding grants or assistance. The bill defines the relevant export-control framework by reference to existing federal regulations, so it would operate by incorporating and relying on current national security and export restriction lists rather than creating a new standalone list.
Impact
HB254 would amend the way the National Science Foundation administers grants and assistance by imposing a categorical eligibility restriction tied to foreign military-linked entities and their affiliates. It would affect universities, researchers, companies, and other applicants that have partnerships or ownership ties to entities appearing on federal restricted lists, potentially disqualifying them from NSF support. The bill would also reinforce the use of existing export-control and defense-related designations in federal research funding decisions, increasing compliance and due diligence obligations for applicants and the agency.
Sentiment
Based on the bill text and the limited available context, the overall sentiment appears supportive of a national-security-focused restriction on federal science funding. The bill was introduced and referred to committee without recorded opposition or vote history in the available materials, suggesting no documented floor-level controversy yet. The framing of the bill as the "American Science First Act" indicates a protective, security-oriented posture toward federal research dollars.
Contention
The main point of contention is likely to be the breadth of the prohibition and its potential to sweep in entities with indirect or historical ties to listed companies, including research partnerships and ownership relationships. Supporters would likely emphasize protecting U.S. research funding from benefiting Chinese military-linked firms, while critics may argue the bill could chill international scientific collaboration, create uncertainty for universities and private-sector researchers, and rely on broad or evolving federal lists that may be difficult to navigate. No specific committee objections or recorded votes are available in the provided context.